Abstract 1013
Background
Carcinoma of unknown primary (CUP) is a heterogeneous entity of malignant epithelial tumors. In general, CUP follows an aggressive biological and clinical behavior. There is generally limited information regarding this issue.
Methods
All patients categorized as having CUP who attended the department of clinical oncology, Menoufia University from January 2013 to December 2015 were included in the study. The patients’ features, investigations and clinical outcomes were collected. Also, time to progression (TTP) and overall survival (OS) were calculated.
Results
The study included 103 patients representing about 2.2% of the total number of patients visited clinical oncology department outpatients’ clinic during the same period. Most of the patients were males, the mean age of the patients was 58 years, pain was the most common presenting symptom, and adenocarcinoma was the most common reported pathological subtype. Only 50.5% of the patients were fit to receive platinum combination chemotherapy. The median TTP was 2 months and the median OS was 3 months. Age, performance status & presenting symptom had statistically significant relation with TTP. While, the baseline performance status, presenting symptoms and pathological subtype had statistically significant relation with OS.
Conclusions
Carcinomas of unknown primary origin are not uncommon tumors in clinical oncology department, Menoufia University with wide varieties of clinical presentations. Baseline performance status, presenting symptoms and pathological subtype had statistically significant relation with OS.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
161 - Concurrent nivolumab and radiotherapy in treatment of lung squamous cell carcinoma
Presenter: Dai Wee Lee
Session: Poster display - Cocktail
Resources:
Abstract
399 - Adenocarcinoma lung with sphenoidal metastasis
Presenter: Manoj Behera
Session: Poster display - Cocktail
Resources:
Abstract
617 - Osimertinib in the Treatment of Leptomeningeal Disease in T790M-negative, EGFR-mutated NSCLC: A Case Report
Presenter: Lawrence Kasherman
Session: Poster display - Cocktail
Resources:
Abstract
636 - Hemodynamic instability caused by cardiac metastases of non-small cell lung cancer- case studies
Presenter: Chia-I Shen
Session: Poster display - Cocktail
Resources:
Abstract
1302 - The long term survival of a 78 year old female diagnosed with Malignant Epithelial Mesothelioma with peritoneal disease on Pembrolizumab plus Pemetrexed and Carboplatin: a case report
Presenter: Katherine Ruth Oracion
Session: Poster display - Cocktail
Resources:
Abstract